KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Share-based Compensation (2016 - 2025)

Petmed Express' Share-based Compensation history spans 16 years, with the latest figure at $300000.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 40.0% year-over-year to $300000.0; the TTM value through Dec 2025 reached $1.7 million, up 131.35%, while the annual FY2025 figure was -$6.6 million, 195.45% down from the prior year.
  • Share-based Compensation reached $300000.0 in Q4 2025 per PETS's latest filing, up from $200000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.8 million in Q4 2022 to a low of -$8.2 million in Q2 2024.
  • Average Share-based Compensation over 5 years is $678400.0, with a median of $1.2 million recorded in 2021.
  • Peak YoY movement for Share-based Compensation: skyrocketed 113.93% in 2022, then crashed 566.14% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $1.4 million in 2021, then increased by 26.43% to $1.8 million in 2022, then dropped by 3.95% to $1.7 million in 2023, then plummeted by 70.59% to $500000.0 in 2024, then tumbled by 40.0% to $300000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Share-based Compensation are $300000.0 (Q4 2025), $200000.0 (Q3 2025), and $600000.0 (Q2 2025).